|
Volumn 28, Issue 3, 2001, Pages 539-556
|
Inflammatory bowel disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOSALICYLIC ACID DERIVATIVE;
ANTIBIOTIC AGENT;
ANTIDIARRHEAL AGENT;
AZATHIOPRINE;
BALSALAZIDE;
BUTYRIC ACID;
CIPROFLOXACIN;
COLESTYRAMINE;
CYCLOSPORIN;
ENEMA;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
METRONIDAZOLE;
MONOCLONAL ANTIBODY;
NARCOTIC ANALGESIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OLSALAZINE;
OMEGA 3 FATTY ACID;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ADENOMATOUS POLYP;
BONE MARROW SUPPRESSION;
CLINICAL FEATURE;
CLINICAL TRIAL;
COLITIS;
COLON CANCER;
CROHN DISEASE;
DELAYED RELEASE FORMULATION;
DIARRHEA;
DIFFERENTIAL DIAGNOSIS;
DRUG FORMULATION;
DRUG INDUCED DISEASE;
DRUG SAFETY;
ENTERITIS;
GASTROINTESTINAL ENDOSCOPY;
GENETIC SUSCEPTIBILITY;
HUMAN;
ILEOSTOMY;
ILEUM POUCH;
IMMUNOREGULATION;
INTESTINE ANASTOMOSIS;
LIVER FIBROSIS;
PREGNANCY;
PRIORITY JOURNAL;
PROCTOCOLECTOMY;
REVIEW;
ULCERATIVE COLITIS;
|
EID: 0034807858
PISSN: 00954543
EISSN: None
Source Type: Journal
DOI: 10.1016/S0095-4543(05)70052-X Document Type: Article |
Times cited : (17)
|
References (31)
|